| Literature DB >> 8727299 |
Abstract
Unrelated donor bone marrow transplants provide the alternative to allogeneic transplants for patients lacking an HLA-matched related family member donor. Because the donor and recipient have greater immunogenetic disparity than related donor transplants, these transplants are associated with a higher rate of immunologic complications. This disparity has also translated into a lower risk of relapse relative to sibling donor transplants, enabling this treatment to offer a cure to advanced-disease patients.Entities:
Mesh:
Substances:
Year: 1996 PMID: 8727299 DOI: 10.1097/00001622-199603000-00002
Source DB: PubMed Journal: Curr Opin Oncol ISSN: 1040-8746 Impact factor: 3.645